-
-
Call more information
660-596-2224 -
Author: Devin Van Gorden ASA Monitor September 2023, Vol. 87, 27. The number of anesthesiologists applying for fellowships after graduating from residency has grown substantially over the last 20 years. From 2017-2020, the percentage of anesthesiologists completing their residency and entering fellowships more than doubled. Fellowship participants will be primed to take on the most complex, […]
Read MoreASA Monitor September 2023, Vol. 87, 15–32. Gel capsules mimic vegetables and promote weight loss Gelesis is a biotech company utilizing biomimicry to tackle obesity and gastrointestinal-related diseases. Its oral hydrogel technology, Plenity, was approved by the FDA in 2019 after clinical studies showed it helped 60% of users lose weight over the course of six […]
Read MoreAuthors: Hyundeok Joo, MD, MAS et al ASA Monitor September 2023, Vol. 87, 1–7. Durable, functionally impactful, and subjectively evident cognitive decline is a feared outcome of anesthesia and surgery, particularly for older adults (Br J Anaesth 2017;118:486-8). We need to look no further than Dr. Daniel Cole, a coauthor of this article and the editor […]
Read MoreAuthor: Mary Dale Peterson, MD, MHA, FACHE, FASA ASA Monitor September 2023, Vol. 87, 11. As a health care executive (HCE), I know first-hand the challenges nearly every hospital and health system faces in today’s constrained environment. While some of the issues may vary regionally, many institutions are having to do more with less due to […]
Read MoreAuthors: Dibash Kumar Das, PhD; Steven Shafer, MD, FASA ASA Monitor September 2023, Vol. 87, 1–4. Hosting the 95th Academy Awards, Jimmy Kimmel opened his monologue by saying, “Everybody looks so great! When I look around this room, I can’t help but wonder, ‘Is Ozempic right for me?’” Semaglutide (Ozempic, Wegovy, and Rybelsus) is blowing up social media […]
Read More